These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 16313190)

  • 21. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
    Leliveld SR; Stitz L; Korth C
    Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical and structural studies of the prion protein polymorphism.
    Petchanikow C; Saborio GP; Anderes L; Frossard MJ; Olmedo MI; Soto C
    FEBS Lett; 2001 Dec; 509(3):451-6. PubMed ID: 11749972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The unfolded state of the murine prion protein and properties of single-point mutants related to human prion diseases.
    Gerum C; Schlepckow K; Schwalbe H
    J Mol Biol; 2010 Aug; 401(1):7-12. PubMed ID: 20541558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of the core structure of lysozyme amyloid fibrils by proteolysis.
    Frare E; Mossuto MF; Polverino de Laureto P; Dumoulin M; Dobson CM; Fontana A
    J Mol Biol; 2006 Aug; 361(3):551-61. PubMed ID: 16859705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis for the protective effect of the human prion protein carrying the dominant-negative E219K polymorphism.
    Biljan I; Giachin G; Ilc G; Zhukov I; Plavec J; Legname G
    Biochem J; 2012 Sep; 446(2):243-51. PubMed ID: 22676969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro conversion of mammalian prion protein into amyloid fibrils displays unusual features.
    Baskakov IV; Bocharova OV
    Biochemistry; 2005 Feb; 44(7):2339-48. PubMed ID: 15709746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prion diseases in man.
    Ironside JW
    J Pathol; 1998 Nov; 186(3):227-34. PubMed ID: 10211109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different prion conformers target the olfactory pathway in sporadic Creutzfeldt-Jakob disease.
    Zanusso G; Ferrari S; Benedetti D; Sbriccoli M; Rizzuto N; Monaco S
    Ann N Y Acad Sci; 2009 Jul; 1170():637-43. PubMed ID: 19686205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prion-like aggregates: infectious agents in human disease.
    Westermark GT; Westermark P
    Trends Mol Med; 2010 Nov; 16(11):501-7. PubMed ID: 20870462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of N-terminal familial mutations in prion protein fibrillization and prion amyloid propagation in vitro.
    Jones EM; Surewicz K; Surewicz WK
    J Biol Chem; 2006 Mar; 281(12):8190-6. PubMed ID: 16443601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fatal familial insomnia].
    Delisle MB; Uro-Coste E; Gray F; Vital C
    Clin Exp Pathol; 1999; 47(3-4):176-80. PubMed ID: 10472737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural insights into alternate aggregated prion protein forms.
    Polano M; Bek A; Benetti F; Lazzarino M; Legname G
    J Mol Biol; 2009 Nov; 393(5):1033-42. PubMed ID: 19720066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conformational variations in an infectious protein determine prion strain differences.
    Tanaka M; Chien P; Naber N; Cooke R; Weissman JS
    Nature; 2004 Mar; 428(6980):323-8. PubMed ID: 15029196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
    Walsh P; Simonetti K; Sharpe S
    Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous beta-helical fold in prion protein: the case of PrP(82-146).
    Saracino GA; Villa A; Moro G; Cosentino U; Salmona M
    Proteins; 2009 Jun; 75(4):964-76. PubMed ID: 19089953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High hydrophobic amino acid exposure is responsible of the neurotoxic effects induced by E200K or D202N disease-related mutations of the human prion protein.
    Corsaro A; Thellung S; Bucciarelli T; Scotti L; Chiovitti K; Villa V; D'Arrigo C; Aceto A; Florio T
    Int J Biochem Cell Biol; 2011 Mar; 43(3):372-82. PubMed ID: 21094273
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and characterization of a spontaneously aggregating amyloid-forming variant of human PrP((90-231)) through phage-display screening of variants randomized between residues 101 and 112.
    Verma A; Sharma S; Ganguly NK; Majumdar S; Guptasarma P; Luthra-Guptasarma M
    Int J Biochem Cell Biol; 2008; 40(4):663-76. PubMed ID: 18023239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlations among morphology, beta-sheet stability, and molecular structure in prion peptide aggregates.
    Petty SA; Adalsteinsson T; Decatur SM
    Biochemistry; 2005 Mar; 44(12):4720-6. PubMed ID: 15779898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scrapie-infected cells, isolated prions, and recombinant prion protein: a comparative study.
    Kneipp J; Miller LM; Spassov S; Sokolowski F; Lasch P; Beekes M; Naumann D
    Biopolymers; 2004 May-Jun 5; 74(1-2):163-7. PubMed ID: 15137116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flexibility of the murine prion protein and its Asp178Asn mutant investigated by molecular dynamics simulations.
    Gsponer J; Ferrara P; Caflisch A
    J Mol Graph Model; 2001; 20(2):169-82. PubMed ID: 11775003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.